Showing results (2431-2440 of 6,968) with videos related to
Sort By:
Pageof 697
Cancer Science|November 28, 2016
Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myelomaYasuhito Suehara, Hiroyuki Takamatsu, Kota Fukumoto, et al.Cancer Science|November 28, 2016
Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinomaTakashi Kijima, Takaaki Arigami, Yasuto Uchikado, et al.Cancer Science|August 12, 2020
LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinomaYanbin Liu, Xingzhi Li, Changming Zhang, et al.Cancer Science|August 10, 2020
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancerYusuke Kagawa, Hiromi Furuta, Takehiro Uemura, et al.Cancer Science|March 29, 2021
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatmentYoshiaki Fujimoto, Eiji Oki, Shichao Qiu, et al.Cancer Science|April 1, 2021
CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinibYuki Kagiyama, Shuhei Fujita, Yutaka Shima, et al.Cancer Science|April 1, 2021
Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancersKohei Yamaguchi, Yoko Matsumoto, Ryo Suzuki, et al.Cancer Science|July 9, 2020
Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogrammingXinyue Wang, Nan Li, Anna Han, et al.Cancer Science|July 9, 2020
Biology and therapeutic potential of mesenchymal stem cell-derived exosomesZhou Xunian, Raghu KalluriCancer Science|July 30, 2020
Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2Juanjuan He, Jing Wang, Songchao Li, et al.Pageof 697